Company Shanghai Bio-heart Biological Technology Co., Ltd.

Equities

2185

CNE100004JH3

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Medical Devices & Implants

SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD.

Market Closed - Hong Kong S.E. Other stock markets 09:08:42 28/06/2024 BST			5-day change	1st Jan Change
1.86 ^HKD	+1.09%		-2.62%	-45.61%

05-22	Shanghai Bio-Heart Biological Technology Co., Ltd. Announces Board and Committee Resignations	CI
03-25	Shanghai Bio-heart Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai Bio-Heart Biological Technology Co Ltd is a China-based company mainly engaged in interventional instruments. The Company's main businesses are the development and production of interventional cardiovascular devices. The Company's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The Company's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension.

Number of employees: 32

Managers	Title	Age	Since
Li Wang CEO	Chief Executive Officer	55	17/07/14
Tao Cai CHM	Chairman	38	30/06/14
Yun Qing Wang DFI	Director of Finance/CFO	40	03/09/20
Bradley Stewart Hubbard CTO	Chief Tech/Sci/R&D Officer	66	28/02/21
Pei Li Wang BRD	Director/Board Member	41	31/12/13
Siu Ying Kwok SEC	Corporate Secretary	40	08/12/20

Members of the board	Title	Age	Since
Li Wang CEO	Chief Executive Officer	55	17/07/14
Xu Bo Lu BRD	Director/Board Member	44	23/11/20
Yun Qing Wang DFI	Director of Finance/CFO	40	03/09/20
Pei Li Wang BRD	Director/Board Member	41	31/12/13
Tao Cai CHM	Chairman	38	30/06/14
Lei Zhu BRD	Director/Board Member	37	09/11/22
Jun Yi Wang BRD	Director/Board Member	35	30/08/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	236,223,322	74,372,224 ( 31.48 %)	0	33.62 %
Stock B	1	7,713,678	7,636,541 ( 99.00 %)	0

Name	Equities	%	Valuation
Li Wang 19.32 %	45,645,584	19.32 %	12 M $
Shanghai Baixinantong Enterprise Management Consulting LP 11.84 %	27,962,081	11.84 %	7 M $
Shanghai Baihate Enterprise Management Consulting LP 10.75 %	25,402,420	10.75 %	6 M $
TPG Partner Holdings Advisors, Inc. 8.785 %	20,753,025	8.785 %	5 M $
Legend Capital Co. Ltd. 5.174 %	12,223,098	5.174 %	3 M $
OrbiMed Advisors Private Equity 4.370 %	10,323,992	4.370 %	3 M $
Loyal Valley Capital Co. Ltd. 4.226 %	9,983,037	4.226 %	3 M $
Snow Lake Management LP 1.233 %	2,911,900	1.233 %	740 700 $
Ching Hung Chau 1.041 %	2,459,700	1.041 %	625 674 $
OrbiMed Advisors LLC 0.4370 %	1,032,400	0.4370 %	262 612 $

Name	Equities	%	Valuation
Tibet Zhenshan Venture Capital Investment LP 16.70 %	16,717,998	16.70 %	4 M $
Shanghai Jiachen Investment Co. Ltd. 9.944 %	9,954,710	9.944 %	3 M $

Shanghai Bio-Heart Biological Technology Co., Ltd.

East Zhangjiang Hi-Tech Park No.590 Ruiqing Road

201201, Shanghai

http://www.bio-heart.com

address Shanghai Bio-heart Biological Technology Co., Ltd.(2185)

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.84

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD.	-45.61%	57.35M
STRYKER CORPORATION	+13.72%	130B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-17.54%	7.17B
GLAUKOS CORPORATION	+47.67%	5.91B
INSPIRE MEDICAL SYSTEMS, INC.	-33.48%	4.02B
AXONICS, INC.	+8.31%	3.44B
ENOVIS CORPORATION	-19.83%	2.46B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-16.33%	1.96B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-24.61%	1.67B
DOUBLE MEDICAL TECHNOLOGY INC.	-36.56%	1.47B

Medical Devices & Implants